Drug Information
General Information | ||||||
---|---|---|---|---|---|---|
Drug ID |
DR01696
|
|||||
Drug Name |
Benzoylphenylurea
|
|||||
Synonyms |
benzoylphenylurea; SCHEMBL83109
|
|||||
Indication | Solid tumours [ICD11: 2D4Z] | Phase 1 | [1] | |||
Structure |
|
|||||
3D MOL | 2D MOL | |||||
Formula |
C14H12N2O2
|
|||||
Canonical SMILES |
C1=CC=C(C=C1)C(=O)N(C2=CC=CC=C2)C(=O)N
|
|||||
InChI |
InChI=1S/C14H12N2O2/c15-14(18)16(12-9-5-2-6-10-12)13(17)11-7-3-1-4-8-11/h1-10H,(H2,15,18)
|
|||||
InChIKey |
XYFMGGWVGACNEC-UHFFFAOYSA-N
|
|||||
Pharmaceutical Properties | Molecular Weight | 240.26 | Topological Polar Surface Area | 63.4 | ||
Heavy Atom Count | 18 | Rotatable Bond Count | 2 | |||
Hydrogen Bond Donor Count | 1 | Hydrogen Bond Acceptor Count | 2 | |||
XLogP |
2.7
|
|||||
PubChem CID | ||||||
DT(s) Transporting This Drug | BCRP | Transporter Info | Breast cancer resistance protein | Substrate | [2] | |
References | ||||||
1 | ClinicalTrials.gov (NCT00010205) Benzoylphenylurea in Treating Patients With Advanced Cancer | |||||
2 | American Association for Cancer Research. |
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.